ANCA-associated vasculitis
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a
group of disorders involving severe, systemic, small-vessel vasculitis and are characterized …
group of disorders involving severe, systemic, small-vessel vasculitis and are characterized …
[HTML][HTML] Eosinophils in health and disease: a state-of-the-art review
Eosinophils play a homeostatic role in the body's immune responses. These cells are
involved in combating some parasitic, bacterial, and viral infections and certain cancers and …
involved in combating some parasitic, bacterial, and viral infections and certain cancers and …
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …
[HTML][HTML] Eosinophilic granulomatosis with polyangiitis: a review
JPE White, S Dubey - Autoimmunity Reviews, 2023 - Elsevier
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, multi-system, inflammatory
disease, belonging to the group of anti-neutrophil cytoplasmic antibody (ANCA)-associated …
disease, belonging to the group of anti-neutrophil cytoplasmic antibody (ANCA)-associated …
Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic
granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the …
granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the …
Update on eosinophilic granulomatosis with polyangiitis
S Furuta, T Iwamoto, H Nakajima - Allergology International, 2019 - jstage.jst.go.jp
abstract Eosinophilic granulomatosis with polyangiitis (EGPA)(formerly Churg-Strauss
syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis …
syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis …
[HTML][HTML] EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
B Hellmich, B Sanchez-Alamo, JH Schirmer… - Annals of the …, 2024 - ard.bmj.com
Background Since the publication of the EULAR recommendations for the management of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …
From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases
Effective treatment of inflammatory diseases is often challenging owing to their
heterogeneous pathophysiology. Understanding of the underlying disease mechanisms is …
heterogeneous pathophysiology. Understanding of the underlying disease mechanisms is …
Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand
J Blakey, LP Chung, VM McDonald, L Ruane… - …, 2021 - Wiley Online Library
Oral corticosteroids (OCS) are frequently used for asthma treatment. This medication is
highly effective for both acute and chronic diseases, but evidence indicates that …
highly effective for both acute and chronic diseases, but evidence indicates that …
Eosinophilic granulomatosis with polyangiitis–advances in pathogenesis, diagnosis, and treatment
J Fijolek, E Radzikowska - Frontiers in Medicine, 2023 - frontiersin.org
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease characterized by
eosinophil-rich granulomatous inflammation and necrotizing vasculitis, pre-dominantly …
eosinophil-rich granulomatous inflammation and necrotizing vasculitis, pre-dominantly …